Esreboxetine

DRUG3 trials

Sponsors

Pfizer

Conditions

Fibromyalgia

Phase 1

Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers

CompletedNCT00809289

PfizerFibromyalgia

Start: 2008-12-31End: 2009-07-31Target: 40Updated: 2011-04-07

Phase 2

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

CompletedNCT00752505

PfizerFibromyalgia

Start: 2008-08-31End: 2009-06-30Updated: 2018-12-04

Phase 3

Maintenance of Efficacy.

WithdrawnNCT00796601

PfizerFibromyalgia

Start: 2009-05-01End: 2010-11-01Updated: 2018-11-29